News & Updates

Uterine atony emerges as leading cause of postpartum haemorrhage

Postpartum haemorrhage most commonly occurs due to uterine atony, according to a systematic review and meta-analysis. Other causes include genital tract trauma, retained placenta, abnormal placentation, and coagulopathy.

Uterine atony emerges as leading cause of postpartum haemorrhage

18 hours ago

Elevated TyG index a red flag for adverse metabolic trajectories, pregnancy outcomes in PCOS

13 May 2025

Among patients with polycystic ovary syndrome (PCOS), a high triglyceride-glucose (TyG) index appears to be associated with adverse metabolic trajectories and pregnancy outcomes, according to a study.

Elevated TyG index a red flag for adverse metabolic trajectories, pregnancy outcomes in PCOS

13 May 2025

TAF prophylaxis prevents mother-to-child transmission of HBV

13 May 2025

Treatment with tenofovir alafenamide (TAF) is generally safe and effective for the prevention of hepatitis B virus (HBV) mother-to-child transmission (MTCT), reports a study, noting that the expected 8-week prenatal duration is feasible.

TAF prophylaxis prevents mother-to-child transmission of HBV

13 May 2025

MIRASOL final analysis: MIRV remains superior to chemo for ovarian cancer

13 May 2025 by

In the final overall survival (OS) analysis of the phase III MIRASOL trial, the survival benefit previously reported with the antibody drug conjugate mirvetuximab soravtansine (MIRV) remains superior to investigator’s choice chemotherapy (ICC) for the treatment of folate receptor alpha-positive, platinum-resistant ovarian cancer (FRα+ PROC).

MIRASOL final analysis: MIRV remains superior to chemo for ovarian cancer

13 May 2025

Intrinsic motivations for healthy lifestyle help reduce postpartum weight

12 May 2025 by

Greater intrinsic motivation for engaging in healthy lifestyle behaviours appears to promote long-term postpartum weight reduction and may be a promising target for interventions, suggests a study.

Intrinsic motivations for healthy lifestyle help reduce postpartum weight

12 May 2025

Exercise reduces odds of lower extremity lymphedema in endometrial cancer

10 May 2025

Regular physical activity appears to protect against lower extremity lymphedema in endometrial cancer survivors, as reported in a study.

Exercise reduces odds of lower extremity lymphedema in endometrial cancer

10 May 2025

C-section, painful childbirth tied to severe pain during medical abortion

09 May 2025

History of caesarean delivery and painful childbirth appear to contribute to severe pain during medical abortion beyond known risk factors of nulliparity, dysmenorrhea, and gestational duration, according to a study.

C-section, painful childbirth tied to severe pain during medical abortion

09 May 2025

BRCA-negative ovarian cancer gets PFS gains with pembrolizumab plus olaparib

08 May 2025 by

First-line treatment with chemotherapy plus pembrolizumab followed by maintenance with pembrolizumab plus olaparib, with or without bevacizumab, appears to prolong progression-free survival (PFS) in advanced epithelial ovarian cancer without BRCA 1/2 mutations, according to data from the phase III ENGOT-ov43/GOG-3036/KEYLYNK-001 trial.

BRCA-negative ovarian cancer gets PFS gains with pembrolizumab plus olaparib

08 May 2025

Add-on bireociclib promising for HR+/HER2- ABC following ET failure

07 May 2025 by

In the interim analysis of the phase III BRIGHT-2 study, adding the CDK4/6 inhibitor bireociclib to fulvestrant prolongs progression-free survival (PFS) in Chinese women with HR+/HER2- advanced breast cancer (ABC) who progressed on or after endocrine therapy (ET).

Add-on bireociclib promising for HR+/HER2- ABC following ET failure

07 May 2025

Pembrolizumab plus CCRT improves survival in locally advanced cervical cancer

07 May 2025 by

Adding pembrolizumab to concurrent chemoradiotherapy (CCRT) improves progression-free survival (PFS) and overall survival (OS) in patients with high-risk, locally advanced cervical cancer (LACC) compared with CCRT alone, according to the second interim analysis of the phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial presented at SGO 2025.

Pembrolizumab plus CCRT improves survival in locally advanced cervical cancer

07 May 2025

News & Updates

Filter by Specialty:

Specialty:

Uterine atony emerges as leading cause of postpartum haemorrhage

Uterine atony emerges as leading cause of postpartum haemorrhage

Elevated TyG index a red flag for adverse metabolic trajectories, pregnancy outcomes in PCOS

Elevated TyG index a red flag for adverse metabolic trajectories, pregnancy outcomes in PCOS

TAF prophylaxis prevents mother-to-child transmission of HBV

TAF prophylaxis prevents mother-to-child transmission of HBV

MIRASOL final analysis: MIRV remains superior to chemo for ovarian cancer

MIRASOL final analysis: MIRV remains superior to chemo for ovarian cancer

Intrinsic motivations for healthy lifestyle help reduce postpartum weight

Intrinsic motivations for healthy lifestyle help reduce postpartum weight

Exercise reduces odds of lower extremity lymphedema in endometrial cancer

Exercise reduces odds of lower extremity lymphedema in endometrial cancer

C-section, painful childbirth tied to severe pain during medical abortion

C-section, painful childbirth tied to severe pain during medical abortion

BRCA-negative ovarian cancer gets PFS gains with pembrolizumab plus olaparib

BRCA-negative ovarian cancer gets PFS gains with pembrolizumab plus olaparib

Add-on bireociclib promising for HR+/HER2- ABC following ET failure

Add-on bireociclib promising for HR+/HER2- ABC following ET failure

Pembrolizumab plus CCRT improves survival in locally advanced cervical cancer

Pembrolizumab plus CCRT improves survival in locally advanced cervical cancer